ACTEMRA 80MG INJECTION

Actemra, 80 mg injection, is a source of an active ingredient called tocilizumab. It is the monoclonal antibody group (a protein derived from particular immune cells). It is prescribed for conditions like severe to moderately active arthritis (RA) and sufferers who have an insufficient response to other drugs for rheumatoid arthritis, such as giant cell arthritis (a disease in the arteries), as well as children with systemic juvenile Idiopathic arthritis (sJIA) or polyarticular juvenile Idiopathic Arthritis (pJIA) that cause swelling and pain in some or all joints in children aged between 1 and 2 years old and over.
Children who experience allergic reactions to the ingredients or severe infections should see their physician before taking the medication. Consult your physician immediately when you experience any allergic reaction (difficulty breathing, tightness in your chest or itching, hives, swelling of the lips or tongue, or even your face) or infections (short chronic) tuberculosis or tuberculosis diverticulitis or ulcers (small pouches that bulge out of the stomach) liver diseases, cancer kidney function issues, and persistent headaches.
Inform your doctor if children have a history of macrophage activation disorder (activation and uncontrolled growth of specific red blood cells). Seniors are more likely to get diseases than people of all ages, so it is essential to be aware when dealing with those with these diseases. Check with your physician if you are planning to have a baby or suspect you are pregnant or nursing.